Section 246-889-070. Retail sales of nonprescription ephedrine, pseudoephedrine, and phenylpropanolamine products.  


Latest version.
  • Purpose.
    The legislature has recognized that restricting access to ephedrine, pseudoephedrine, and phenylpropanolamine products, or their salts or isomers, or salts of isomers, is a valid method to reduce the availability of these products for the manufacture of methamphetamine. To reduce the use of these products in the manufacture of methamphetamine, while continuing access for legitimate purposes, the legislature directed the board to adopt rules to implement a statewide methamphetamine precursor tracking system for the nonprescription sales of products containing ephedrine, pseudoephedrine or phenylpropanolamine or their salts or isomers, or salts of isomers. This chapter describes the requirements for the retail sales of restricted products.
    [Statutory Authority: RCW 69.43.165 and 18.64.005. WSR 11-19-018, § 246-889-070, filed 9/8/11, effective 10/15/11. Statutory Authority: RCW 69.43.170, 18.64.005. WSR 06-02-010, § 246-889-070, filed 12/22/05, effective 1/1/06.]
RCW 69.43.165 and 18.64.005. WSR 11-19-018, § 246-889-070, filed 9/8/11, effective 10/15/11. Statutory Authority: RCW 69.43.170, 18.64.005. WSR 06-02-010, § 246-889-070, filed 12/22/05, effective 1/1/06.